China SXT Pharmaceuticals, Inc.
SXTC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,251 | -$1,251 | -$401 | -$401 |
| Dep. & Amort. | $223 | $223 | $78 | $78 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $122 | $122 | -$542 | -$542 |
| Other Non-Cash | $412 | $412 | $187 | $187 |
| Operating Cash Flow | -$494 | -$494 | -$679 | -$679 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $12 | $12 | $20 | $20 |
| Investing Cash Flow | $11 | $11 | $20 | $20 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $581 | $581 | $3,619 | $3,619 |
| Financing Cash Flow | $581 | $581 | $3,619 | $3,619 |
| Forex Effect | -$290 | -$290 | $258 | $258 |
| Net Chg. in Cash | $0 | $0 | $0 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $0 | $0 |
| End Cash | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$495 | -$495 | -$679 | -$679 |